KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for AbbVie (ABBV) over the last 15 years, with Q3 2025 value amounting to $5.7 billion.

  • AbbVie's Cash & Current Investments fell 2215.51% to $5.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 billion, marking a year-over-year decrease of 2215.51%. This contributed to the annual value of $5.6 billion for FY2024, which is 5665.57% down from last year.
  • As of Q3 2025, AbbVie's Cash & Current Investments stood at $5.7 billion, which was down 2215.51% from $6.5 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's Cash & Current Investments ranged from a high of $18.1 billion in Q1 2024 and a low of $5.2 billion during Q1 2025
  • For the 5-year period, AbbVie's Cash & Current Investments averaged around $9.6 billion, with its median value being $9.2 billion (2022).
  • Its Cash & Current Investments has fluctuated over the past 5 years, first crashed by 7623.6% in 2021, then soared by 16880.39% in 2024.
  • Quarter analysis of 5 years shows AbbVie's Cash & Current Investments stood at $9.8 billion in 2021, then decreased by 6.11% to $9.2 billion in 2022, then soared by 38.87% to $12.8 billion in 2023, then plummeted by 56.66% to $5.6 billion in 2024, then grew by 2.09% to $5.7 billion in 2025.
  • Its last three reported values are $5.7 billion in Q3 2025, $6.5 billion for Q2 2025, and $5.2 billion during Q1 2025.